• H&Z
    H&Z Management Consulting - Consulting with head, heart and hand

    MedTech

    The industry is confronted with massively disrupted supply chains and new regulations of the EU-MDR – these developments require resilient supply chains and innovative approaches.

    Microscope
    1. Home
      2. /
    2. Sectors
      3. /
    3. MedTech

    Supply chain resilience and development velocity as key factors for long-term success

    The high growth of the MedTech industry in the past years currently runs the risk to be slowed down by two main factors: Supply Chain disruption and the new requirements of the EU-MDR. While Covid-19, the Ukraine war and the energy crisis hinder production capabilities and increases costs significantly, companies also have to cope with a delay in new innovations.  These issues need to be tackled by increasing the resilience of supply chains together with implementing measures that shorten development times.

    CT tube

    Resilient Supply Chains

    A resilient supply chain in MedTech, ensures more than an enhanced absorbing capacity to essential materials supply shocks. Resilient supply chains stands for adaptability, risk mitigation, operational efficiency, customer satisfaction, transparency, collaboration, and ultimately, the sustained success of your business.

    The MedTech industry is being confronted with massively disrupted supply chains, in which theavailability of essential materials is compromised, delivery dates are postponed or even completely suspended.  Concurrently, compounding conjunctural challenges and a mounting burden of regulatory scrutiny imperil the crucial innovative momentum, adding incremental pressure within the MedTech Industry.


    At H&Z we are specialists in helping our clients to strategically develop a more resilient and trustworthy supply chain, with the objective to ensure production continuity and service delivery. We believe that a stronger and empowered supply chain will directly translate to an overall enhanced performance. Our seasoned professionals, boasting extensive careers in the industry, possess the precise expertise required to proficiently execute the essential modifications to your procurement processes and supply chain, making it more resilient and adaptable to external shocks than ever before.

    Production

    Product Life Cycle Management

    The unprecedented evolution pace of medical technologies presents companies with unparalleled opportunities but also requires continuous adaptation and innovation to remain competitive, relevant, and ahead of the curve in today's MedTech dynamic business landscape.

    Ensuring a well-orchestrated product portfolio while considering the synchronization of new product pipeline and extensions to existing products, plays a crucial to thrive in nowadays competitive MedTech industry. The pivotal factor in delivering innovation, driving change, and achieving customer objectives lies in the effective management of this product portfolio, which requires precise prioritization and a well-calibrated resource allocation. 

     

    At H&Z we convert lifecycle managing into a competitive advantage; we are experts in assessing the strategic product life cycle of products in the MedTech industry and determining where and when to make the next investments.

    Laboratory

    Process optimization

    Process optimization is a vital catalyst for success in MedTech, where competition and regulations intensify, and the cost of product malfunctions is high. It harmonizes cost-efficiency with quality standards, essential in precision-driven MedTech.

    While monitoring the market is crucial, introspection into the processes of your own company is equally vital. In the MedTech Industry, the consequences of medical device malfunctions are not just financial but have profound implications for human well-being. Process optimization emerges as the guardian to find the much-needed optimized blend between quality and efficiency.

     

    At H&Z, we specialize in pinpointing areas for improvement, crafting finely tuned processes tailored to MedTech's unique demands, propelling your organization to new heights.

    Laboratory Health Research

    Development velocity

    Regulatory approval processes are putting an increasing burden on the development timeline for new products. Thus, it becomes a key success factor in a fast-paced and dynamic market, that companies accelerate their development velocity to stay ahead of the wave and beat the competition. By doing so, companies optimize their resources and focus on what matters most.

    Development velocity is not putting time pressure on a process. It is about carefully orchestrating a strategy that focuses on core products, uses agile methods, and delegates work packages to optimize the product development, boosting productivity and keeping the innovation pipeline flowing.

     

    At H&Z, we provide the right knowledge to lead you through the entire product lifecycle, from ideation to launch, using modern development frameworks and agile formats. We can help you speed up your development velocity and deliver innovation value to your customers in the shortest time possible.

    You might be also interested in

    iStock-1329033617.jpg
    01/12/2022publications

    Staying ahead in the MedTech Industry

    Our recent study highlights the big challenges facing MedTech companies and how to stay ahead of the competition

    Our Experts for Medtech

    Hans-Martin Lauer

    LinkedIn
    E-Mail
    Hans-Martin Lauer

    Patrik Soltendieck

    LinkedIn
    E-Mail
    Patrick Soltendieck

    Sebastian Rudloff

    LinkedIn
    E-Mail
    Sebastian Rudloff